Sreeya Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -93.78%
- Profit Growth -34.72%
- Ebitda -3783.85%
- Net Worth 12.81%
- Total Assets 23.99%
About Sreeya Pharma
Sreeya Pharma Private Limited (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 04 January 2019 (Six years and one month 19 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Alluru Ashokreddy, Vijaya Alluru, and Sriram Alluru serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999TG2019PTC129501
- Company No.
129501
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Jan 2019
- Date of AGM
31 Jul 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Sreeya Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Alluru Ashokreddy  | Director | 04-Jan-2019 | Current |
| Vijaya Alluru | Director | 04-Jan-2019 | Current |
| Sriram Alluru | Director | 02-Jan-2023 | Current |
Financial Performance of Sreeya Pharma.
Sreeya Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 93.78% decrease. The company also saw a substantial fall in profitability, with a 34.72% decrease in profit. The company's net worth Soared by an impressive increase of 12.81%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sreeya Pharma?
Unlock access to Sreeya Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Total Drugs And Intermediates Private LimitedAlluru Ashokreddy is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sreeya Pharma?
Unlock and access historical data on people associated with Sreeya Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sreeya Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sreeya Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.